Tag: neuromodulation market size

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Neuromodulation Market Growth in 2025?

There has been a rapid expansion in the size of the neuromodulation market in the preceding years. The market, valued at $6.96 billion in 2024, is predicted to escalate to $7.68 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.3%. The historic period’s growth can be ascribed to an increased prevalence of chronic conditions, corroborating clinical research, patient preference for non-invasive treatment options, government-led initiatives and financial backing, widening usage indications, and strategic collaborations and partnerships.

What Is the Forecast for the Neuromodulation Market Size Through 2029?

The neuromodulation market is predicted to experience significant expansion in the coming years, with the market projected to reach a value of “$11.79 billion by 2029, reflecting a compound annual growth rate (CAGR) of 11.3%. The predicted growth in the forecast period is due to factors such as the miniaturization of devices, a growing emphasis on neurological disorders in the elderly, broadened uses in psychiatry, patient-centric methods, and enhanced global healthcare access. Key trends expected to shape the sector during the forecast period are the incorporation of artificial intelligence (AI), progress in technology, the introduction of non-invasive neuromodulation techniques, the development of closed-loop neuromodulation systems, widening of indications, and the emergence of wireless and wearable neuromodulation devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What are the Key Market Players in Neuromodulation Market and How They’re Evolving?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

What Are the Primary Growth Drivers in the Neuromodulation Market?

The intensifying occurrence of neurological disorders is anticipated to drive the neuromodulation market’s expansion. Neurological disorders are fundamentally characterized as issues that influence the brain, along with nerves existing throughout the human body and the spinal cord. Neuromodulation offers the potential to treat and modify a variety of neurological disorders and diseases, including Parkinson’s and Alzheimer’s diseases. For example, as observed by the European Brain Council in April 2022, a coordinating international health organization based in Belgium, there were more than 600 neurological diseases, and almost 300 psychiatric conditions recorded. Globally, 50 million people were living with Alzheimer’s and other forms of dementia. Epilepsy, a common disorder, affected 65 million people worldwide. In Europe, dementia was found in 10.5 million individuals, projected to rise to 18.7 million by 2050. Therefore, the increasing occurrence of neurological disorders is fuelling the expansion of the neuromodulation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

What Are the Leading Segments in the Global Neuromodulation Industry?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

What Are the Key Market Trends in the Neuromodulation Industry?

Rapid advancements in technology are becoming a prominent trend within the neuromodulation market. To consolidate their market stance, several key companies are investing in the development of innovative technical solutions. Take for example GrayMatters Health, an entity hailing from Israel that specializes in digital self-neuromodulation therapies. In January 2024, they unveiled Prism, an FDA-approved self-neuromodulation therapy for PTSD. This ground-breaking device, which blends an EEG cap with software, empowers patients to regulate their emotional reactions through neurofeedback. The inventive technology is aimed to enhance conventional psychotherapy and pharmacotherapy by providing patients with active symptom management tools. Furthermore, Abbott Laboratories, a US medical devices and healthcare firm, launched in December 2022 the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable and rechargeable spinal cord stimulator on the market. The Eterna SCS uses Abbott’s unique low-dose BurstDR stimulation that holds the highest level of clinical proof (1A evidence). It has proven to augment pain relief by an additional 23% over regular waveform technology methods.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Is the Regional Outlook for the Neuromodulation Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

This Report Delivers Insight On:

1. How big is the neuromodulation market, and how is it changing globally?

2. Who are the major companies in the neuromodulation market, and how are they performing?

3. What are the key opportunities and risks in the neuromodulation market right now?

4. Which products or customer segments are growing the most in the neuromodulation market?

5. What factors are helping or slowing down the growth of the neuromodulation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the neuromodulation industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Projected Market Size and Growth Rates for the Neuromodulation Market From 2025 To 2029?

Recently, the neuromodulation market has experienced swift expansion. The market, which is expected to increase from $6.96 billion in 2024 to $7.68 billion in 2025, will do so at a compound annual growth rate (CAGR) of 10.3%. The notable growth during the past years is linked to the increasing instances of chronic diseases, relevant clinical findings and research, patient preference for non-invasive treatments, government policies and funding, expansion of treatment indications, and collaborations and partnerships.

Over the coming years, the neuromodulation market is anticipated to experience fast-paced expansion, with expectations to reach an impressive size of “$11.79 billion in 2029, reflecting a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in this period can be explained by several factors, including the shrinking of devices, increased attention on neurological disorders among the elderly, broader usage in the psychiatric field, patient-oriented methods, and improved global healthcare accessibility. Trends that are expected to stand out include the incorporation of artificial intelligence (AI), technological advancements, non-invasive techniques of neuromodulation, closed-loop neuromodulation systems, expansion of specifications, as well as the introduction of wireless and wearable neuromodulation devices.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?

The rise in occurrences of neurological disorders is anticipated to fuel the expansion of the neuromodulation market in the future. Neurological issues, technically considered ailments that impact the brain, the nerves dispersed across the human body, and the spinal cord, can be treated and modulated by neuromodulation. This includes a spectrum of neurological diseases and disorders like Parkinson’s and Alzheimer’s. For example, the European Brain Council, a Belgium-based international health coordination organization, reported in April 2022 that there were more than 600 neurological diseases and close to 300 psychiatric conditions recognized. Globally, there were 50 million people coping with Alzheimer’s and other forms of dementia. Epilepsy, another ubiquitous disorder, affected 65 million individuals worldwide. In Europe alone, there were 10.5 million people diagnosed with dementia, a figure that’s expected to surge to 18.7 million by 2050. Consequently, the increasing incidence of neurological disorders is stimulating the neuromodulation market’s growth.

Which Segments in the Neuromodulation Offer the Most Growth?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?# Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Current Market Growth and Trends in the Neuromodulation Industry?

There is an increasing trend for technological developments within the neuromodulation market. Major businesses within this industry are focusing heavily on creating new tech-solutions to solidify their market standing. For instance, GrayMatters Health, a company from Israel with expertise in digital self-neuromodulation therapies, introduced its innovative product, Prism, to the market in January 2024. This FDA-approved therapy for PTSD utilizes an EEG cap and software that assists patients in controlling emotional responses through neurofeedback. This cutting-edge technology complements traditional psychotherapy and pharmacotherapy, giving patients an active role in symptom management. In December 2022, Abbott Laboratories, a U.S. based firm in the medical devices and healthcare field, unveiled the Eterna spinal cord stimulation (SCS) system – the smallest implantable, rechargeable spinal cord stimulator currently available. The Eterna SCS utilizes Abbott’s exclusive low-dose BurstDR stimulation, the only SCS waveform advancement with the top-level 1A evidence of effectiveness, proven to reduce pain by 23% more than standard waveform tech-approaches.

View the full report here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Are the Key Elements That Define the Neuromodulation Market?

Neuromodulation is the modification of nerve activity (or modulation) by delivering electrical or pharmacological substances directly to a specific location. It is a reversible procedure performed to relieve pain.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?

The neuromodulation market’s expansion is anticipated to be driven by the increasing incidence of neurological disorders. These disorders primarily impact the brain, nerves spread across the body, and the spinal cord. Neuromodulation offers potential treatments for numerous neurological conditions and diseases, including Parkinson’s and Alzheimer’s diseases. For example, the European Brain Council, a Belgium-based international health organization, reported in April 2022 that there were over 600 neurological diseases and around 300 psychiatric conditions. Globally, 50 million people were living with Alzheimer’s and other forms of dementia. Epilepsy, another widespread disorder, impacted 65 million individuals globally. In Europe, dementia was seen in 10.5 million individuals, projected to rise to 18.7 million by 2050. Therefore, the increasing incidence of neurological disorders is fueling the growth of the neuromodulation market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What is the Predicted Annual Growth Rate of theNeuromodulation Market Impact Industry Trends by 2034?

The scale of the neuromodulation market has rapidly expanded in the past few years. The market is set to escalate from $6.96 billion in 2024 to $7.68 billion in 2025, with a projected compound annual growth rate (CAGR) of 10.3%. Factors such as an increased occurrence of chronic diseases, reliable clinical data and research, patients’ preference for non-intrusive treatments, government schemes and financial assistance, extension of indications, and collaborative endeavors and partnerships have all contributed to the remarkable growth experienced in the historic period.

It’s projected that the neuromodulation market will experience substantial expansion in the coming years. The market is set to inflate to “$11.79 billion in 2029 with a compound annual growth rate (CAGR) of 11.3%. This projected growth within the forecast period can be associated with the reduction in size of devices, focus on neurological diseases in the elderly population, increased use in psychiatry, patient-oriented strategies, and a broader international access to healthcare. Future trends within the forecasted period comprise the incorporation of artificial intelligence (ai), technological advancements, non-invasive neuromodulation methods, closed-loop neuromodulation systems, expansion in usage, wearable and wireless neuromodulation devices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

What Are the Current Market Growth and Trends in theNeuromodulation Market That Industry Players Should Watch?

A prominent emerging trend in the neuromodulation market is the focus on technological innovation. Leading companies in this space are determined to forge ahead by creating cutting-edge technological alternatives. Take for instance, GrayMatters Health, a leading entity from Israel that specialises in digital self-neuromodulation therapies, rolled out its groundbreaking FDA-approved self-neuromodulation therapy device named Prism in January 2024 to combat PTSD. This revolutionary tool that pairs an EEG cap with exclusive software, teaches patients how to regulate their emotional reactions via neurofeedback. The technology aims to supplement traditional psychotherapy and pharmacotherapy, empowering patients with the necessary mechanisms to actively control their symptoms. Additionally, in December 2022, Abbott Laboratories, an American medical devices and healthcare leader, unveiled the Eterna spinal cord stimulation (SCS) system, recognized as the smallest rechargeable, implantable spinal cord stimulator. Abbott’s Eterna SCS uses the company’s proprietary low-dose BurstDR stimulation, which is the only SCS waveform innovation supported by the highest level of clinical evidence (1A), proven to alleviate pain by an extraordinary 23% more than typical waveform technology strategies.

What Are the Major Market Players Making an Impact on theNeuromodulation Market Growth?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

How Are the Key Segments of the Neuromodulation Market Driving Opportunities and Innovations?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theNeuromodulation Market?# Market Expansion?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Neuromodulation Maret 2025, By The Business Research Company:

Neurophysiology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Neurodegenerative Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Interventional Neurology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the neuromodulation market size evolved in recent years?

The scale of the neuromodulation market has expanded swiftly in the past few years. It is projected to rise from $6.96 billion in 2024 to $7.68 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. The historical growth can be traced back to factors such as an increase in chronic disorders, medical research, and documented evidence, an inclination for non-invasive therapies from patients, governmental support and financing, extension of indications, plus collaborations and alliances.

What are the predictions for the neuromodulation market size in the coming years?

The neuromodulation market is predicted to experience a surge in growth in the coming years, expected to reach “$11.79 billion by 2029, with a compound annual growth rate (CAGR) of 11.3%. The projected acceleration during the forecast period can be linked to the shrinking size of devices, emphasis on neurological illnesses in the elderly, broader use in psychiatry, patient-focused strategies, and worldwide improvement of healthcare accessibility. Major trends to look out for during the forecast period include the incorporation of artificial intelligence (AI), technological advancements, non-invasive neuromodulation methods, closed-loop neuromodulation systems, expanded disease indications for usage, as well as the development of wireless and wearable neuromodulation devices.

Get your neuromodulation market report here!

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What key factors are fueling the growth of the neuromodulation market?

The escalation of neurological conditions is anticipated to be a major driver for the expansion of the neuromodulation market. Neurological conditions are technically classified as issues affecting the brain, nerves spread across the body, and the spinal cord. Neuromodulation provides potential treatment options and the ability to regulate a broad range of neurological diseases like Parkinson’s and Alzheimer’s. For example, in April 2022, the Belgium based European Brain Council, an international health organization reported over 600 neurological diseases and approximately 300 psychiatric conditions. Globally, Alzheimer’s and other forms of dementia affected 50 million individuals. Epilepsy, a common neurological disorder, affected 65 million individuals worldwide. In Europe, dementia was prevalent in 10.5 million people, and this number is projected to rise to 18.7 million by 2050. Therefore, the escalating prevalence of neurological disorders is catalyzing the expansion of the neuromodulation market.

How is the global neuromodulation market divided into key segments?

The neuromodulation market covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

Who are the key firms paving the way for growth in the neuromodulation market?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Which trends are expected to transform the neuromodulation market?

Key technological advancements are an emerging trend in the neuromodulation market. Leading businesses in the sector are prioritizing the creation of novel technology solutions to secure their standing. To exemplify, GrayMatters Health, a company based in Israel renowned for its digital self-neuromodulation therapies, debuted an FDA-approved self-neuromodulation therapy labeled Prism for PTSD patients in January 2024. This ground-breaking tool, integrating an EEG cap and software, assists patients in managing their emotional reactions using neurofeedback. The system is configured to improve conventional psychotherapy and pharmacotherapy, giving patients the means to proactively manage their symptoms. Moving on, in December 2022, Abbott Laboratories, a US-based medical devices and healthcare firm, introduced the Eterna spinal cord stimulation (SCS) system, recognized as the smallest, rechargeable implantable spinal cord stimulator. The Eterna SCS utilizes Abbott’s uniquely patented low-dose BurstDR stimulation, the sole SCS waveform innovation with the highest level of clinical proof (1A evidence). It has demonstrated its effectiveness in pain relief, outperforming traditional waveform technology methods by 23%.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10142

What regions are contributing significantly to the growth of the neuromodulation market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Neurophysiology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Neurodegenerative Disorder Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Interventional Neurology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/interventional-neurology-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: